5-Amino-1MQ Explained: NNMT, NAD⁺, and Fat Cell Metabolism
Summary
This episode of Peptides Explained addresses listener requests by analyzing 5-amino-1MQ, clarifying that it is a small molecule NNMT inhibitor rather than a peptide. The host details its proposed mechanism involving NAD+ and methylation, reviewing promising preclinical animal data on fat loss and metabolic health. However, the discussion emphasizes the lack of human clinical trials and FDA approval, urging listeners to distinguish between early scientific interest and proven therapeutic efficacy.
Topics discussed
Sponsor ads for Toyota and REI
Podcast intro, disclaimer, and episode announcements
Introduction to 5-amino-1MQ and its classification
What is 5-amino-1MQ? NNMT inhibition explained
The biology of fat tissue and adipocytes
Detailed mechanism: NAD+, methylation, and SAM pathways
Preclinical evidence: Cell and animal study data
Comparison to GLP-1s and other peptides
Regulatory status and FDA warnings
Addressing online hype and anecdotal evidence
Sponsor break and N=1 segment announcement
Summary and final conclusions
Sponsor ads for USAA and LifeLock
Listen ad-free on Castria